DRD1a Activators
SEE ALSO...
Items 1 to 10 of 13 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, potentially mimicking the effect of DRD1a activation and leading to compensatory changes in receptor expression. | ||||||
SCH 23390 | 125941-87-9 | sc-200408 sc-200408A | 5 mg 25 mg | $175.00 $719.00 | 2 | |
SCH-23390 is a potent and selective antagonist for the DRD1a receptor, which inhibits dopamine binding and receptor signaling, thus inhibiting DRD1a function. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
Rolipram inhibits phosphodiesterase-4, which increases cAMP levels, potentially affecting the cAMP-responsive elements that regulate DRD1a expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium butyrate is a histone deacetylase inhibitor that may increase the acetylation of histones, affecting the transcription of various genes, possibly including DRD1a. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Valproic acid is another histone deacetylase inhibitor that can lead to changes in gene expression through epigenetic modifications. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 5 g 100 g 250 g 1 kg 5 kg | $32.00 $66.00 $95.00 $188.00 $760.00 | 13 | |
Caffeine, as an adenosine receptor antagonist, indirectly influences dopaminergic signaling and could alter the expression of dopamine receptors. | ||||||
Clozapine | 5786-21-0 | sc-200402 sc-200402A | 50 mg 500 mg | $68.00 $357.00 | 11 | |
Clozapine is an atypical antipsychotic that, while having a higher affinity for D4 receptors, can antagonize DRD1a receptors as well, reducing their activity. | ||||||
Haloperidol | 52-86-8 | sc-507512 | 5 g | $190.00 | ||
Haloperidol, a dopamine receptor antagonist, might induce upregulation of dopamine receptors, including DRD1a, as a compensatory mechanism. | ||||||
Levodopa | 59-92-7 | sc-205372 sc-205372A | 5 g 25 g | $53.00 $168.00 | 9 | |
L-DOPA is a precursor to dopamine and might affect dopamine receptor expression due to increased dopamine synthesis. | ||||||
Tetrabenazine | 58-46-8 | sc-204338 sc-204338A | 10 mg 50 mg | $165.00 $707.00 | ||
Tetrabenazine depletes dopamine stores by inhibiting vesicular monoamine transporter 2 (VMAT2), which indirectly leads to the reduced stimulation of DRD1a due to lower synaptic dopamine levels. | ||||||